{"product_id":"active-pharmaceutical-ingredients-api-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","title":"Active Pharmaceutical Ingredients (API) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028","description":"\u003cp\u003eActive Pharmaceutical Ingredients (API) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028\u003cbr\u003eThe global active pharmaceutical ingredients (API) market size reached US$ 222.9 Billion in 2022. Looking forward, McKinsey \u0026amp; Well expects the market to reach US$ 303.9 Billion by 2028, exhibiting a growth rate (CAGR) of 5.6% during 2023-2028.\u003c\/p\u003e\n\u003cp\u003eActive pharmaceutical ingredient (API), is the term that is used to refer to the biologically active component of a drug (e.g. tablet, capsule). A drug is usually composed of several components. The API represents the primary ingredient. Other ingredients are commonly known as \"excipients. Sometimes a drug can contain several APIs and its effect on a patient depends on the dosage prescribed and can vary from person to person. In combination therapies, two or more than two active ingredients are used to treat different symptoms in different ways. Stringent quality control is a mandate when it comes to the manufacturing of drugs as the API represents the main component considered while making the prescription.\u003c\/p\u003e\n\u003cp\u003ePharmaceutical manufacturing occurs in two general steps. In the first step, manufacturers convert raw materials into APIs. The second step involves creating the final formulation by mixing APIs and excipients into tablets, capsules, solutions, etc. and finally packaging the drug for the end users. Manufacturers either sell APIs in the open market (also known as the merchant market) or use them as inputs to make their final formulations. The global API market is extremely competitive with a number of large and small manufacturers. Firms that engage in API manufacturing generally specialize and target their manufacturing based on a combination of the firms in-house skills and market opportunities. Catalyzed by lower costs, API manufacturing has gradually been shifting from the historical leaders in Western countries to manufacturers based in India and China.\u003c\/p\u003e\n\u003cp\u003eThe global demand of APIs is currently exhibiting strong growth. One of the major drivers of this market is the rising number of blockbuster patent expiries creating a significant opportunity for generic APIs. Moreover, there has been a strong demand for APIs for biologicals. The global market for biologicals is currently exhibiting strong growth catalyzed by their high potency and ability to treat diseases beyond the scope of small molecule drugs. This is creating a strong demand for APIs for branded biological drugs and their biosimilar versions. Other factors catalyzing the global demand of APIs include ageing population, rising expenditures on healthcare, increasing prevalence of lifestyle diseases, etc.\u003c\/p\u003e\n\u003cp\u003eKey Market Segmentation:\u003c\/p\u003e\n\u003cp\u003eMcKinsey \u0026amp; Well provides an analysis of the key trends in each sub-segment of the global active pharmaceutical ingredients (API) market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on drug type, type of manufacturer, type of synthesis and therapeutic application.\u003c\/p\u003e\n\u003cp\u003eBreakup by Drug Type:\u003c\/p\u003e\n\u003cp\u003eInnovative Active Pharmaceutical Ingredients (API)\u003c\/p\u003e\n\u003cp\u003eGeneric Active Pharmaceutical Ingredients (API)\u003c\/p\u003e\n\u003cp\u003eBased on the drug type, the market has been segmented as innovative active pharmaceutical ingredients and generic active pharmaceutical ingredients.\u003c\/p\u003e\n\u003cp\u003eBreakup by Type of Manufacturer:\u003c\/p\u003e\n\u003cp\u003eCaptive Manufacturers\u003c\/p\u003e\n\u003cp\u003eMerchant API Manufacturers\u003c\/p\u003e\n\u003cp\u003eInnovative Merchant API Manufacturers\u003c\/p\u003e\n\u003cp\u003eGeneric Merchant API Manufacturers\u003c\/p\u003e\n\u003cp\u003eBased on the type of manufacturer, the market has been segmented as captive manufacturers and merchant API manufacturers.\u003c\/p\u003e\n\u003cp\u003eBreakup by Type of Synthesis:\u003c\/p\u003e\n\u003cp\u003eSynthetic Active Pharmaceutical Ingredients (API)\u003c\/p\u003e\n\u003cp\u003eMarket Breakup by Type\u003c\/p\u003e\n\u003cp\u003eInnovative Synthetic APIs\u003c\/p\u003e\n\u003cp\u003eGeneric Synthetic APIs\u003c\/p\u003e\n\u003cp\u003eBiotech Active Pharmaceutical Ingredients (API)\u003c\/p\u003e\n\u003cp\u003eMarket Breakup by Type\u003c\/p\u003e\n\u003cp\u003eInnovative Biotech APIs\u003c\/p\u003e\n\u003cp\u003eBiosimilars\u003c\/p\u003e\n\u003cp\u003eMarket Breakup By Product\u003c\/p\u003e\n\u003cp\u003eMonoclonal Antibodies\u003c\/p\u003e\n\u003cp\u003eVaccines\u003c\/p\u003e\n\u003cp\u003eCytokines\u003c\/p\u003e\n\u003cp\u003eFusion Proteins\u003c\/p\u003e\n\u003cp\u003eTherapeutic Enzymes\u003c\/p\u003e\n\u003cp\u003eBlood Factors\u003c\/p\u003e\n\u003cp\u003eMarket Breakup By Expression System\u003c\/p\u003e\n\u003cp\u003eMammalian Expression Systems\u003c\/p\u003e\n\u003cp\u003eMicrobial Expression Systems\u003c\/p\u003e\n\u003cp\u003eYeast Expression Systems\u003c\/p\u003e\n\u003cp\u003eTransgenic Animal Systems\u003c\/p\u003e\n\u003cp\u003eOthers\u003c\/p\u003e\n\u003cp\u003eBased on the type of synthesis, the market has been segmented as synthetic active pharmaceutical ingredients and biotech active pharmaceutical ingredients.\u003c\/p\u003e\n\u003cp\u003eBreakup by Therapeutic Application:\u003c\/p\u003e\n\u003cp\u003eOncology\u003c\/p\u003e\n\u003cp\u003eCardiovascular and Respiratory\u003c\/p\u003e\n\u003cp\u003eDiabetes\u003c\/p\u003e\n\u003cp\u003eCentral Nervous System Disorders\u003c\/p\u003e\n\u003cp\u003eNeurological Disorders\u003c\/p\u003e\n\u003cp\u003eOthers\u003c\/p\u003e\n\u003cp\u003eBased on the therapeutic application, the market has been segmented as oncology, cardiovascular \u0026amp; respiratory, diabetes, central nervous system disorders, neurological disorders and others.\u003c\/p\u003e\n\u003cp\u003eBreakup by Region:\u003c\/p\u003e\n\u003cp\u003eNorth America\u003c\/p\u003e\n\u003cp\u003eUnited States\u003c\/p\u003e\n\u003cp\u003eCanada\u003c\/p\u003e\n\u003cp\u003eEurope\u003c\/p\u003e\n\u003cp\u003eGermany\u003c\/p\u003e\n\u003cp\u003eFrance\u003c\/p\u003e\n\u003cp\u003eUnited Kingdom\u003c\/p\u003e\n\u003cp\u003eItaly\u003c\/p\u003e\n\u003cp\u003eSpain\u003c\/p\u003e\n\u003cp\u003eRussia\u003c\/p\u003e\n\u003cp\u003eOthers\u003c\/p\u003e\n\u003cp\u003eAsia Pacific\u003c\/p\u003e\n\u003cp\u003eChina\u003c\/p\u003e\n\u003cp\u003eJapan\u003c\/p\u003e\n\u003cp\u003eIndia\u003c\/p\u003e\n\u003cp\u003eSouth Korea\u003c\/p\u003e\n\u003cp\u003eAustralia\u003c\/p\u003e\n\u003cp\u003eIndonesia\u003c\/p\u003e\n\u003cp\u003eOthers\u003c\/p\u003e\n\u003cp\u003eLatin America\u003c\/p\u003e\n\u003cp\u003eMiddle East and Africa\u003c\/p\u003e\n\u003cp\u003eRegion-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.\u003c\/p\u003e\n\u003cp\u003eCompetitive Landscape:\u003c\/p\u003e\n\u003cp\u003eThe competitive landscape of the market has also been examined with some of the (active pharmaceutical ingredients companies) key players being Pfizer, Inc., Novartis International AG, Sanofi, Boehringer Ingelheim, Bristol-Myers Squibb, Teva Pharmaceutical Industries Ltd., ELI Lilly and Company, GlaxoSmithKline, Merck \u0026amp; Co., Inc. and Abbvie Inc.\u003c\/p\u003e\n\u003cp\u003eKey Questions Answered in This Report\u003c\/p\u003e\n\u003cp\u003e1. How big is the active pharmaceutical ingredient market?\u003c\/p\u003e\n\u003cp\u003e2. What is the expected growth rate of the global Active Pharmaceutical Ingredients (API) market during 2023-2028?\u003c\/p\u003e\n\u003cp\u003e3. What are active ingredients in pharmaceutical industry?\u003c\/p\u003e\n\u003cp\u003e4. What are the key factors driving the global Active Pharmaceutical Ingredients (API) market?\u003c\/p\u003e\n\u003cp\u003e5. What has been the impact of COVID-19 on the global Active Pharmaceutical Ingredients (API) market?\u003c\/p\u003e\n\u003cp\u003e6. What is the breakup of the global Active Pharmaceutical Ingredients (API) market based on the drug type?\u003c\/p\u003e\n\u003cp\u003e7. What is the breakup of the global Active Pharmaceutical Ingredients (API) market based on the type of manufacturer?\u003c\/p\u003e\n\u003cp\u003e8. What is the breakup of the global Active Pharmaceutical Ingredients (API) market based on the type of synthesis?\u003c\/p\u003e\n\u003cp\u003e9. What is the breakup of the global Active Pharmaceutical Ingredients (API) market based on the therapeutic application?\u003c\/p\u003e\n\u003cp\u003e10. What are the key regions in the global Active Pharmaceutical Ingredients (API) market?\u003c\/p\u003e\n\u003cp\u003e11. Who is the biggest API manufacturer?\u003c\/p\u003e\n\u003cp\u003e12. Who are the key players\/companies in the global Active Pharmaceutical Ingredients (API) market?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"May, 2023 \/ 138 Pages \/ MCW16230214","offer_id":47647057510706,"sku":null,"price":2999.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/active-pharmaceutical-ingredients-api-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}